— Know what they know.
Not Investment Advice
Also trades as: GRF.MC (BME) · $vol 20M · GIFLF (OTC) · $vol 0M · GIFOF (OTC) · $vol 0M · GIKLY (OTC) · $vol 0M

GRFS NASDAQ

Grifols, S.A.
1W: -0.5% 1M: -6.6% 3M: +1.9% YTD: -20.9% 1Y: -26.7% 3Y: -18.5% 5Y: -51.6%
$7.31
+0.01 (+0.14%)
 
Weekly Expected Move ±2.8%
$7 $7 $7 $8 $8
NASDAQ · Healthcare · Drug Manufacturers - General · Tech Score Strong Sell · Power 36 · $6.2B mcap · 835M float · 0.075% daily turnover · Short 32% of daily vol

Cash Flow Trends

Operating Cash Flow
$1.0B +11.5% ▲
5Y CAGR: -2.0%
Capital Expenditures
$255M +31.5% ▲
5Y CAGR: -1.9%
Free Cash Flow
$751M +41.5% ▲
5Y CAGR: -2.0%
Dividends Paid
$123M -12680.5% ▼
Buybacks
$124M +0.0% ▲
Net Change in Cash
-$39M -108.6% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income$189M$361M$207M$444M$386M
Depreciation & Amort.$360M$408M$446M$438M$432M
Stock-Based Comp.$0$0$0$0$0
Change in Working Capital-$181M-$609M-$363M$22M-$24M
Other Non-Cash Items$230M-$171M-$72M-$2M$211M
Operating Cash Flow$597M-$11M$219M$902M$1.0B
— Investing Activities —
Capital Expenditures-$247M-$376M-$224M-$233M-$406M
Acquisitions (Net)-$519M-$1.4B-$29M-$286M-$100M
Investment Purchases$0-$165M-$93M-$44M-$55M
Investment Sales$0$0$15M$0$5M
Other Investing-$88M$3M-$63M$1.4B$0
Investing Cash Flow-$854M-$2.0B-$395M$887M-$556M
— Financing Activities —
Net Debt Issuance$2.7B-$104M-$116M-$111M-$183M
Stock Repurchased-$126M-$3M$0$0-$124M
Dividends Paid-$252M-$592K$0-$962K-$123M
Other Financing-$71M-$65M$288M-$1.2B-$79M
Financing Cash Flow$2.3B-$173M$171M-$1.4B-$508M
Net Change in Cash$2.1B-$2.1B-$20M$450M-$39M
Cash End of Period$2.7B$548M$530M$980M$825M
Free Cash Flow$350M-$386M-$92M$531M$751M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms